Citius Pharmaceuticals (CTXR) Accumulated Expenses (2011 - 2026)
Citius Pharmaceuticals (CTXR) recorded Accumulated Expenses of $25.91 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 204.0% from $8.52 million a year earlier and up 7.4% from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Accumulated Expenses (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals reported Accumulated Expenses of $4.19 million.
- Annual Accumulated Expenses has a five-year compound annual growth rate of 75.2% (FY2020 to FY2025).
- Across earlier fiscal years, Accumulated Expenses came in at $17,027 in FY2024 (-96.4%), $476,300 in FY2023 (-66.1%), $1.41 million in FY2022 (+126.0%) and $621,960 in FY2021 (+144.9%).
- The fiscal Q3 2026 figure is the highest quarterly Accumulated Expenses in data going back to fiscal Q3 2011.
- On a year-over-year basis, Accumulated Expenses rose in two of the last four quarters, with growth averaging 64.4%.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 805.4% in fiscal Q1 2022, against a decline of 96.4% in fiscal Q4 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $24.14 million (Q2 2026), $4.69 million (Q1 2026) and $4.19 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Citius Pharmaceuticals | 13.45 Mn | -10.82 Mn | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.91 Mn |
| Mar 31, 2026 | 24.14 Mn |
| Dec 31, 2025 | 4.69 Mn |
| Sep 30, 2025 | 4.19 Mn |
| Jun 30, 2025 | 8.52 Mn |
| Mar 31, 2025 | 8.78 Mn |
| Dec 31, 2024 | 6.24 Mn |
| Sep 30, 2024 | 17,027.00 |
| Jun 30, 2024 | 550,485.00 |
| Mar 31, 2024 | 151,204.00 |
| Dec 31, 2023 | 276,897.00 |
| Sep 30, 2023 | 476,300.00 |
| Jun 30, 2023 | 892,874.00 |
| Mar 31, 2023 | 2.25 Mn |
| Dec 31, 2022 | 690,402.00 |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 621,960.00 |
API Access
Citius Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();